Previous close | 75.94 |
Open | 75.58 |
Bid | 74.92 x 100 |
Ask | 75.33 x 100 |
Day's range | 73.52 - 75.58 |
52-week range | 55.02 - 98.40 |
Volume | |
Avg. volume | 733,736 |
Market cap | 3.568B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript May 6, 2024 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.44233 EPS, expectations were $-1.2. Axsome Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
Discover how Axsome Therapeutics achieved a 160% revenue increase and navigated heightened R&D and operational costs in Q1 2024.
Q1 2024 Axsome Therapeutics Inc Earnings Call